|
Volumn 49, Issue 3, 2002, Pages 201-208
|
Aerosol orgotein (Ontosein®) for the prevention of radiotherapy-induced adverse effects in head and neck cancer patients: A feasibility study
a a a a a |
Author keywords
Cancer; Head and neck cancer; Orgotein; Radiation therapy; Radiation induced adverse effects
|
Indexed keywords
COBALT 60;
SUPEROXIDE DISMUTASE;
ADULT;
AEROSOL;
AGED;
ARTICLE;
CANCER RADIOTHERAPY;
CANCER STAGING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
DYSPHAGIA;
FEMALE;
GLOTTIS;
HEAD CANCER;
HUMAN;
LARYNX EDEMA;
MALE;
MUCOSA INFLAMMATION;
NEBULIZER;
NECK CANCER;
PROPHYLAXIS;
RADIATION HAZARD;
RADIATION SICKNESS;
SKIN MANIFESTATION;
TREATMENT OUTCOME;
XEROSTOMIA;
|
EID: 0036300161
PISSN: 00282685
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (38)
|